Cytek Biosciences (CTKB) Other financing activities (2020 - 2026)
Cytek Biosciences (CTKB) posted Other financing activities of $21000.0 for Q1 2026, down 75.29% on a QoQ basis from $85000.0 in Q4 2025, and down 46.15% year-over-year from $39000.0 in Q1 2025.
Cytek Biosciences (CTKB) Other financing activities (2020 - 2026) Analysis & Trends
Cytek Biosciences' Other financing activities history runs 7 years deep, the most recent figure standing at $21000.0 for Q1 2026.
- Quarterly Other financing activities fell 46.15% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307000.0 (down 43.98% YoY) and the FY2025 annual result came in at $325000.0, down 67.98% from the prior year.
- Other financing activities was $21000.0 for Q1 2026 at Cytek Biosciences, down from $85000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $763000.0 in Q2 2023 and bottomed at $21000.0 in Q1 2026.
- A 5-year average of $237235.3 and a median of $168000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 243.08% in 2022, while the deepest fall reached 99.9% in 2022.
- Cytek Biosciences' Other financing activities stood at $168000.0 in 2022, then surged by 102.98% to $341000.0 in 2023, then slumped by 59.53% to $138000.0 in 2024, then slumped by 38.41% to $85000.0 in 2025, then tumbled by 75.29% to $21000.0 in 2026.
- Business Quant data shows CTKB's Other financing activities at $21000.0 in Q1 2026, $85000.0 in Q4 2025, and $137000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Dec 31, 2023 | 341,000.00 |